Skip to content

Testosterone therapy increased heart rhythm problems in men with low testosterone

Compared with placebo, testosterone replacement increased heart rhythm disorders in trials of men with low testosterone. Differences in deaths, strokes and heart attacks remained statistically uncertain.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

For men in these trials, testosterone replacement increased reported heart rhythm disorders compared with placebo. The analysis did not detect statistically significant differences in overall deaths, cardiovascular deaths, strokes or heart attacks. Those uncertain results do not establish equal safety, and the rhythm finding should remain part of the overall interpretation.

Keep in mind

The abstract does not provide absolute event rates or describe which rhythm disorders occurred. It therefore cannot show how many additional men experienced an arrhythmia or how serious those events were.

THE RESULT, WITH CONTEXT

What researchers found

Heart rhythm disorders were more frequent with testosterone

Incidence of cardiac arrhythmias

Testosterone versus placebo over at least 12 months: risk ratio 1.53 (95% confidence interval 1.20–1.97). This compares event risks, not absolute numbers affected.

Am J Cardiovasc Drugs, 2025 · Original source ↓

What the main result means

An arrhythmia is a heart rhythm disorder. The pooled risk ratio compared its occurrence between treatment groups. Its confidence interval stayed above the value indicating equal risk, supporting the reported increase while leaving its precise size uncertain.

Why the other results remain uncertain

For deaths, strokes and heart attacks, the statistical ranges included equal risk. The trials therefore did not clearly distinguish the groups for those outcomes. This differs from demonstrating that testosterone and placebo have identical risks.

CHECK THE ORIGINAL

The original publication

Long-Term Cardiovascular Safety of Testosterone-Replacement Therapy in Middle-Aged and Older Men: A Meta-analysis of Randomized Controlled Trials.

Braga MAP, Rivera A, Marinheiro G et al.
Am J Cardiovasc Drugs · 2025

PubMed ID
40694252
Record checked

Linked publication notices

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.